Literature DB >> 12724497

Reversible dementia due to thalidomide therapy for multiple myeloma.

Alexander E Morgan, Wade K Smith, James L Levenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12724497     DOI： 10.1056/NEJM200305013481822

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Current status of stem cell transplantation for multiple myeloma.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Suzanne Hayman
Journal:  Curr Treat Options Oncol       Date:  2005-05

2.  Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations.

Authors:  K L Hallene; E Oby; B J Lee; S Santaguida; S Bassanini; M Cipolla; N Marchi; M Hossain; G Battaglia; D Janigro
Journal:  Neuroscience       Date:  2006-07-20       Impact factor: 3.590

3.  Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial.

Authors:  Boris Decourt; Denise Drumm-Gurnee; Jeffrey Wilson; Sandra Jacobson; Christine Belden; Sherye Sirrel; Michael Ahmadi; Holly Shill; Jessica Powell; Aaron Walker; Amanda Gonzales; Mimi Macias; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 4.  Treatment and disease-related complications in multiple myeloma: Implications for survivorship.

Authors:  Rajshekhar Chakraborty; Navneet S Majhail
Journal:  Am J Hematol       Date:  2020-03-13       Impact factor: 10.047

5.  BK channel blocker paxilline attenuates thalidomide-caused synaptic and cognitive dysfunctions in mice.

Authors:  Tae-Yong Choi; Seung-Hyun Lee; Soo-Jeong Kim; Youhwa Jo; Chul-Seung Park; Se-Young Choi
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

Review 6.  Epidemiology, Staging, and Management of Multiple Myeloma.

Authors:  Sandeep Anand Padala; Adam Barsouk; Alexander Barsouk; Prashanth Rawla; Anusha Vakiti; Ravindra Kolhe; Vamsi Kota; Germame Hailegiorgis Ajebo
Journal:  Med Sci (Basel)       Date:  2021-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.